Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Naba Alsaha Medical Services CoSAU:9546 58 Median PS Value is ﷼0.00 as of Jul. 17, 2026. GuruFocus rates SAU:9546 with a GF Score™ of 58/100 and a GF Value™ of ﷼42.04 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 262 Healthcare Providers & Services companies, Naba Alsaha Medical Services Co ranks worse than 381679.01% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for Naba Alsaha Medical Services Co's Median PS Value or its related term are showing as below:
SAU:9546's Price-to-Median-PS-Value is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 0.71 * Ranked among companies with meaningful Price-to-Median-PS-Value only.
Naba Alsaha Medical Services Co (SAU:9546) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Naba Alsaha Medical Services Co's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
21.38
/
0.00
=
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Naba Alsaha Medical Services Co Median PS Value Related Terms
Naba Alsaha Medical Services Co Median PS Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Naba Alsaha Medical Services Co Median PS Value Chart
SAU:9546 vs HCA, THC, DVA: Median PS Value Comparison
For the Medical Care Facilities subindustry, Naba Alsaha Medical Services Co's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Naba Alsaha Medical Services Co Price-to-Median-PS-Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Naba Alsaha Medical Services Co's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Naba Alsaha Medical Services Co's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 0.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Naba Alsaha Medical Services Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was ﷼9.61.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Naba Alsaha Medical Services Co (SAU:9546) has a Median PS Value of ﷼0.00 as of Jul. 17, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Naba Alsaha Medical Services Co and its competitors. According to the industry distribution chart, Naba Alsaha Medical Services Co ranks #999999 out of 262 companies in the Healthcare Providers & Services industry.
Is Naba Alsaha Medical Services Co's Median PS Value too high?
Naba Alsaha Medical Services Co's current Median PS Value is ﷼0.00. Based on the distribution chart, Naba Alsaha Medical Services Co ranks #999999 out of 262 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Naba Alsaha Medical Services Co has a GF Score™ of 58/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Naba Alsaha Medical Services Co's Median PS Value compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Naba Alsaha Medical Services Co ranks #999999 out of 262 companies for Median PS Value. This places Naba Alsaha Medical Services Co in the lower half of its industry. The industry median Median PS Value is 0.71. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Healthcare Providers & Services company?
The median Median PS Value among Healthcare Providers & Services companies is 0.71, based on 262 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Naba Alsaha Medical Services Co and its competitors. For the Healthcare Providers & Services industry, the median Median PS Value is 0.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Naba Alsaha Medical Services Co's current Median PS Value is ﷼0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Naba Alsaha Medical Services Co stock overvalued right now?
Based on GuruFocus' analysis, Naba Alsaha Medical Services Co (SAU:9546) is currently considered Significantly Undervalued. The stock's GF Value™ is ﷼42.04, compared to a current price of ﷼21.38 — trading 49.1% below its estimated fair value. The current Median PS Value is ﷼0.00. Naba Alsaha Medical Services Co's overall GF Score™ is 58/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Naba Alsaha Medical Services Co (SAU:9546), the current Median PS Value is ﷼0.00 as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Naba Alsaha Medical Services Co (SAU:9546) Overvalued in 2026?
Based on GuruFocus' analysis, Naba Alsaha Medical Services Co stock appears to be undervalued.
The current stock price of ﷼21.38 is trading 49.1% below its estimated GF Value™ of ﷼42.04.
GuruFocus considers Naba Alsaha Medical Services Co to be Significantly Undervalued.
Key valuation signals for SAU:9546:
Median PS Value: ﷼0.00
GF Value™: ﷼42.04 vs. price of ﷼21.38 (49.1% below fair value)
No single metric tells the full story. See the SAU:9546 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Naba Alsaha Medical Services Co Business Description
Naba Alsaha Medical Services Co is engaged in the medical operation of private and government hospitals, health facilities, and hospital-related activities. It operates and manages Al-Zahraa Hospital, Manarat Al-Haramain Pharmacy, and the Nabaa Al-Saha branch for the practice of maintenance work and the operation of buildings. Geographically, it operates in the Kingdom of Saudi Arabia.
58GF Score
Get the complete analysis for SAU:9546
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:9546 has been successfully added to your 
